DE60016288D1 - Isolierung von vorläuferzellen und deren verwendung zum wiederaufbau von bindegewebe - Google Patents

Isolierung von vorläuferzellen und deren verwendung zum wiederaufbau von bindegewebe

Info

Publication number
DE60016288D1
DE60016288D1 DE60016288T DE60016288T DE60016288D1 DE 60016288 D1 DE60016288 D1 DE 60016288D1 DE 60016288 T DE60016288 T DE 60016288T DE 60016288 T DE60016288 T DE 60016288T DE 60016288 D1 DE60016288 D1 DE 60016288D1
Authority
DE
Germany
Prior art keywords
marker
expressed
precursor cells
detectable
morphogenic protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60016288T
Other languages
English (en)
Other versions
DE60016288T2 (de
Inventor
Frank Luyten
Bari Cosimo De
Accio Francesco Dell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tigenix NV
Original Assignee
Tigenix NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tigenix NV filed Critical Tigenix NV
Priority to DE20023640U priority Critical patent/DE20023640U1/de
Publication of DE60016288D1 publication Critical patent/DE60016288D1/de
Application granted granted Critical
Publication of DE60016288T2 publication Critical patent/DE60016288T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1317—Chondrocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DE60016288T 1999-10-06 2000-10-06 Isolierung von vorläuferzellen und deren verwendung zum wiederaufbau von bindegewebe Expired - Lifetime DE60016288T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE20023640U DE20023640U1 (de) 1999-10-06 2000-10-06 Isolierung von Vorläuferzellen und deren Verwendung zum Wiederaufbau von Bindegewebe

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP99203274 1999-10-06
EP99203274 1999-10-06
EP99203290 1999-10-07
EP99203290 1999-10-07
PCT/BE2000/000120 WO2001025402A1 (en) 1999-10-06 2000-10-06 Isolation of precursor cells and their use for tissue repair

Publications (2)

Publication Number Publication Date
DE60016288D1 true DE60016288D1 (de) 2004-12-30
DE60016288T2 DE60016288T2 (de) 2005-12-01

Family

ID=26153376

Family Applications (2)

Application Number Title Priority Date Filing Date
DE20023640U Expired - Lifetime DE20023640U1 (de) 1999-10-06 2000-10-06 Isolierung von Vorläuferzellen und deren Verwendung zum Wiederaufbau von Bindegewebe
DE60016288T Expired - Lifetime DE60016288T2 (de) 1999-10-06 2000-10-06 Isolierung von vorläuferzellen und deren verwendung zum wiederaufbau von bindegewebe

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE20023640U Expired - Lifetime DE20023640U1 (de) 1999-10-06 2000-10-06 Isolierung von Vorläuferzellen und deren Verwendung zum Wiederaufbau von Bindegewebe

Country Status (10)

Country Link
US (2) US7863045B2 (de)
EP (1) EP1282690B9 (de)
AT (1) ATE283349T1 (de)
AU (1) AU7634400A (de)
CA (1) CA2386506C (de)
DE (2) DE20023640U1 (de)
DK (1) DK1282690T3 (de)
ES (1) ES2230157T3 (de)
PT (1) PT1282690E (de)
WO (1) WO2001025402A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482114B2 (en) 1999-10-06 2009-01-27 Tigenix N.V. In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation
ES2234673T3 (es) 1999-10-06 2005-07-01 Tigenix N.V. Prueba in vivo para verificar la estabilidad fenotipica.
AU2002309330A1 (en) * 2001-05-17 2002-11-25 Isotis N.V. Isolation method of mesenchymal cells
US7375077B2 (en) 2003-09-19 2008-05-20 The Board Of Trustees Of The University Of Illinois In vivo synthesis of connective tissues
EP1576957A1 (de) 2004-03-18 2005-09-21 Universiteit Twente Wiederherstellung zerstörten Gewebes mit Hilfe von pluripotenten Zellen
RU2008141279A (ru) 2006-03-20 2010-04-27 Тижени Н. В. (Be) Способы сохранения, улучшения и восстановления хрящевого фенотипа хондроцитов
EP2094310B1 (de) 2006-11-24 2013-12-25 Tigenix N.V. Markergene zur verwendung bei der identifizierung von chondrozyten-phänotypischer stabilität und beim screenen von faktoren zur beeinflussung der knorpelproduktion
WO2010031876A1 (en) 2008-09-22 2010-03-25 Universiteit Gent Carboxyethylated cyclodextrin polysulfates useful as medicaments
ES2370794B1 (es) * 2010-05-25 2012-10-31 Servicio Andaluz De Salud Biomarcador de células cartilaginosas humanas.
WO2012048275A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
JP6612227B2 (ja) 2013-11-16 2019-11-27 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
EP3122866B1 (de) 2014-03-25 2019-11-20 Terumo BCT, Inc. Passives ersetzen von medien
JP6830059B2 (ja) 2014-09-26 2021-02-17 テルモ ビーシーティー、インコーポレーテッド スケジュール化された細胞フィーディング
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
JP7034949B2 (ja) 2016-05-25 2022-03-14 テルモ ビーシーティー、インコーポレーテッド 細胞の増殖
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11692174B2 (en) * 2017-02-08 2023-07-04 Sapphiros Ai Bio Llc Systems, methods, and apparatus for induced pluripotent stem cell isolation and combinatorial production
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
CN110612344B (zh) 2017-03-31 2023-09-12 泰尔茂比司特公司 细胞扩增
WO2019118768A1 (en) * 2017-12-13 2019-06-20 Rita Perlingeiro Enhanced differentiation and maturation of pluripotent stem cell-derived myogenic cells
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5904717A (en) * 1986-01-28 1999-05-18 Thm Biomedical, Inc. Method and device for reconstruction of articular cartilage
US5226914A (en) * 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5197985A (en) * 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5733542A (en) * 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6010696A (en) * 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5811094A (en) * 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5837539A (en) * 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
EP0801675B1 (de) * 1994-07-29 2003-04-16 The United States of America, as Represented by the Secretary, Department of Agriculture Saccharomyces-behandlung zur verringerung von campylobakter- und salmonella-populationen in geflügel
US5972703A (en) * 1994-08-12 1999-10-26 The Regents Of The University Of Michigan Bone precursor cells: compositions and methods
US5648219A (en) * 1995-06-07 1997-07-15 Zymogenetics, Inc. Immortalized dendritic cells
US5683906A (en) * 1994-09-09 1997-11-04 Zymogenetics, Inc. Preparation of immortalized cells
EP0804554A1 (de) * 1994-09-09 1997-11-05 ZymoGenetics, Inc. Herstellung von immortalisierten zellen
US5830682A (en) * 1994-09-09 1998-11-03 Zymogenetics Preparation of immortalized cells
AU715996B2 (en) * 1995-06-12 2000-02-17 Ramot University Authority For Applied Research And Industrial Development Ltd. FGFR3 as a marker for mesenchymal skeletal progenitor cells
WO1997007200A1 (en) * 1995-08-16 1997-02-27 The Board Of Trustees Of The Leland Stanford Junior University Adult oligodendrocyte precursor cell compositions and methods
JP2000503542A (ja) * 1996-01-16 2000-03-28 デピュイ オーソピーディック，インコーポレイテッド 造血及び非造血組織からの前駆細胞の分離及び ｉｎ ｖｉｖｏ 骨及び軟骨再生におけるそれらの使用
US6200606B1 (en) * 1996-01-16 2001-03-13 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US5919702A (en) * 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
WO1998035022A1 (en) * 1997-02-06 1998-08-13 Osiris Therapeutics, Inc. p21?CIP1 OR p27KIP1¿ EFFECTS ON THE REGULATION OF DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS
AU7984498A (en) 1997-06-25 1999-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Serum-free cell growth medium
US6235527B1 (en) * 1997-11-29 2001-05-22 University Of Utah Research Foundation Lineage restricted glial precursors from the central nervous system

Also Published As

Publication number Publication date
CA2386506C (en) 2012-02-21
ATE283349T1 (de) 2004-12-15
EP1282690B9 (de) 2005-03-02
PT1282690E (pt) 2005-02-28
EP1282690A1 (de) 2003-02-12
DE20023640U1 (de) 2005-06-23
ES2230157T3 (es) 2005-05-01
DE60016288T2 (de) 2005-12-01
US20090123927A1 (en) 2009-05-14
US7863045B2 (en) 2011-01-04
DK1282690T3 (da) 2005-02-28
US20110158960A1 (en) 2011-06-30
WO2001025402A1 (en) 2001-04-12
CA2386506A1 (en) 2001-04-12
EP1282690B1 (de) 2004-11-24
AU7634400A (en) 2001-05-10

Similar Documents

Publication Publication Date Title
DE60016288D1 (de) Isolierung von vorläuferzellen und deren verwendung zum wiederaufbau von bindegewebe
Ambrosi et al. A revised perspective of skeletal stem cell biology
Gelain et al. Designer self-assembling peptide nanofiber scaffolds for adult mouse neural stem cell 3-dimensional cultures
Crigler et al. Isolation of a mesenchymal cell population from murine dermis that contains progenitors of multiple cell lineages
Phillips et al. Directed differentiation of human induced pluripotent stem cells toward bone and cartilage: in vitro versus in vivo assays
Kleinman et al. Matrigel: basement membrane matrix with biological activity
Wang et al. Mechanomics: an emerging field between biology and biomechanics
Julien et al. Dual functional activity of semaphorin 3B is required for positioning the anterior commissure
Watt Epidermal stem cells: markers, patterning and the control of stem cell fate
WO2005103716A3 (en) Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
Delannet et al. Transforming growth factor-β control of cell-substratum adhesion during avian neural crest cell emigration in vitro
Tsuchiya et al. Osteogenic differentiation capacity of porcine dental follicle progenitor cells
Fleming et al. Bioengineered human skeletal muscle capable of functional regeneration
Vinante et al. Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesis
Jones Isolation and characterization of human epidermal stem cells
CN107567494A (zh) 间充质干细胞的细胞培养方法
KR102263824B1 (ko) 심장 세포 배양 재료
Viil et al. Laminin-rich blood vessels display activated growth factor signaling and act as the proliferation centers in Dupuytren’s contracture
Lund et al. sdf1 Expression reveals a source of perivascular-derived mesenchymal stem cells in zebrafish
CN102482645A (zh) 与干细胞活性相关的凝血栓蛋白1、凝血栓蛋白2、白细胞介素17b受体和肝素结合表皮生长因子样生长因子和其应用
Williams et al. Engineering the CNS stem cell microenvironment
Arnesen et al. The effects of collagen type I topography on myoblasts in vitro
CN102212460A (zh) 干细胞筛选系统、其制备方法及干细胞的筛选方法
Stanke et al. The early expression of VAChT and VIP in mouse sympathetic ganglia is not induced by cytokines acting through LIFRβ or CNTFRα
Theodorescu et al. TGF-β gene expression depends on tissue architecture

Legal Events

Date Code Title Description
8364 No opposition during term of opposition